SeaStar Medical Holding Corp (ICU)
0.4896
+0.02
(+4.28%)
USD |
NASDAQ |
May 02, 16:00
0.4896
0.00 (0.00%)
After-Hours: 17:18
SeaStar Medical SG&A Expense (Quarterly): 1.868M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.868M |
| September 30, 2023 | 1.829M |
| June 30, 2023 | 1.743M |
| March 31, 2023 | 2.797M |
| December 31, 2022 | 4.701M |
| Date | Value |
|---|---|
| September 30, 2022 | 1.042M |
| June 30, 2022 | 0.716M |
| March 31, 2022 | 0.457M |
| June 30, 2021 | 0.652M |
| March 31, 2021 | 0.316M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.316M
Minimum
Mar 2021
4.701M
Maximum
Dec 2022
1.612M
Average
1.392M
Median
SG&A Expense (Quarterly) Benchmarks
| Nuwellis Inc | 3.609M |
| Ardelyx Inc | 47.75M |
| Adverum Biotechnologies Inc | 10.88M |
| Aquestive Therapeutics Inc | 9.55M |
| Vir Biotechnology Inc | 43.09M |